J
Juan G. Ripoll
Researcher at Mayo Clinic
Publications - Â 38
Citations - Â 2061
Juan G. Ripoll is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 11, co-authored 31 publications receiving 1409 citations. Previous affiliations of Juan G. Ripoll include Tulane University & Louisiana State University.
Papers
More filters
Journal ArticleDOI
Early safety indicators of COVID-19 convalescent plasma in 5000 patients.
Michael J. Joyner,R. Scott Wright,DeLisa Fairweather,Jonathon W. Senefeld,Katelyn A. Bruno,Stephen A. Klassen,Rickey E. Carter,Allan M. Klompas,Chad C. Wiggins,John R. A. Shepherd,Robert F. Rea,Emily R. Whelan,Andrew J. Clayburn,Matthew R. Spiegel,Patrick W. Johnson,Elizabeth R. Lesser,Sarah E. Baker,Kathryn F. Larson,Juan G. Ripoll,Kylie J. Andersen,David O. Hodge,Katie L. Kunze,Matthew R. Buras,Matthew N.P. Vogt,Vitaly Herasevich,Joshua J. Dennis,Riley J. Regimbal,Philippe R. Bauer,Janis E. Blair,Camille M. van Buskirk,Jeffrey L. Winters,James R. Stubbs,Nigel Paneth,Nicole C. Verdun,Peter W. Marks,Arturo Casadevall +35 more
TL;DR: Early indicators suggest that transfusion of convalescent plasma is safe in hospitalized patients with COVID-19, and given the deadly nature of COVID 19 and the large population of critically-ill patients, the mortality rate does not appear excessive.
Journal ArticleDOI
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.
Michael J. Joyner,Rickey E. Carter,Jonathon W. Senefeld,Stephen A. Klassen,John Mills,Patrick W. Johnson,Elitza S. Theel,Chad C. Wiggins,Katelyn A. Bruno,Allan M. Klompas,Elizabeth R. Lesser,Katie L. Kunze,Matthew A. Sexton,Juan C. Diaz Soto,Sarah E. Baker,John R. A. Shepherd,Noud van Helmond,Nicole C. Verdun,Peter W. Marks,Camille M. van Buskirk,Jeffrey L. Winters,James R. Stubbs,Robert F. Rea,David O. Hodge,Vitaly Herasevich,Emily R. Whelan,Andrew J. Clayburn,Kathryn F. Larson,Juan G. Ripoll,Kylie J. Andersen,Matthew R. Buras,Matthew N.P. Vogt,Joshua J. Dennis,Riley J. Regimbal,Philippe R. Bauer,Janis E. Blair,Nigel Paneth,De Lisa Fairweather,R. Scott Wright,Arturo Casadevall +39 more
TL;DR: In this paper, the anti-SARS-CoV-2 antibody levels in convalescent plasma used to treat hospitalized adults with Covid-19 were determined based on a U.S. national registry, and the primary outcome was death within 30 days after plasma transfusion.
Journal ArticleDOI
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients.
Michael J. Joyner,Katelyn A. Bruno,Stephen A. Klassen,Katie L. Kunze,Patrick W. Johnson,Elizabeth R. Lesser,Chad C. Wiggins,Jonathon W. Senefeld,Allan M. Klompas,David O. Hodge,John R. A. Shepherd,Robert F. Rea,Emily R. Whelan,Andrew J. Clayburn,Matthew R. Spiegel,Sarah E. Baker,Kathryn F. Larson,Juan G. Ripoll,Kylie J. Andersen,Matthew R. Buras,Matthew N.P. Vogt,Vitaly Herasevich,Joshua J. Dennis,Riley J. Regimbal,Philippe R. Bauer,Janis E. Blair,Camille M. van Buskirk,Jeffrey L. Winters,James R. Stubbs,Noud van Helmond,Brian P. Butterfield,Matthew A. Sexton,Juan C. Diaz Soto,Nigel Paneth,Nicole C. Verdun,Peter W. Marks,Arturo Casadevall,De Lisa Fairweather,Rickey E. Carter,R. Scott Wright +39 more
TL;DR: New data provide robust evidence that transfusion of convalescent plasma is safe in hospitalized patients with COVID-19, and support the notion that earlier administration of plasma within the clinical course of CO VID-19 is more likely to reduce mortality.
Posted ContentDOI
Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience
Michael J. Joyner,Jonathon W. Senefeld,Stephen A. Klassen,John Mills,Patrick W. Johnson,Elitza S. Theel,Chad C. Wiggins,Katelyn A. Bruno,Allan M. Klompas,Elizabeth R. Lesser,Katie L. Kunze,Matthew A. Sexton,Juan C. Diaz Soto,Sarah E. Baker,John R. A. Shepherd,Noud van Helmond,Camille M. van Buskirk,Jeffrey L. Winters,James R. Stubbs,Robert F. Rea,David O. Hodge,Vitaly Herasevich,Emily R. Whelan,Andrew J. Clayburn,Kathryn F. Larson,Juan G. Ripoll,Kylie J. Andersen,Matthew R. Buras,Matthew N.P. Vogt,Joshua J. Dennis,Riley J. Regimbal,Philippe R. Bauer,Janis E. Blair,Nigel Paneth,DeLisa Fairweather,R. Scott Wright,Rickey E. Carter,Arturo Casadevall +37 more
TL;DR: The relationships between reduced mortality and both earlier time to transfusion and higher antibody levels provide signatures of efficacy for convalescent plasma in the treatment of hospitalized COVID-19 patients.
Journal ArticleDOI
Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1.
Alan D. Kaye,Mark R. Jones,Adam M. Kaye,Juan G. Ripoll,Vincent Galan,Burton D. Beakley,Francisco Calixto,Jamie L. Bolden,Richard D. Urman,Laxmaiah Manchikanti +9 more
TL;DR: The current state of knowledge regarding the growing problem of opioid abuse and misuse; known risk factors; and methods of predicting, assessing, monitoring, and addressing opioid Abuse and misuse in patients with chronic non-cancer pain are reviewed.